|1.||Barthuber, Carmen: 1 article (05/2014)|
|2.||Schulz, Jan: 1 article (05/2014)|
|3.||van Caster, Patrick: 1 article (05/2014)|
|4.||Plitzko, Gabriel: 1 article (05/2014)|
|5.||Bicknell, Leonie: 1 article (05/2014)|
|6.||Pannen, Benedikt H: 1 article (05/2014)|
|7.||Bauer, Inge: 1 article (05/2014)|
|8.||Braun, Sebastian: 1 article (05/2014)|
|9.||Preckel, Benedikt: 1 article (05/2014)|
|10.||Thamprasert, K: 1 article (02/2014)|
01/01/2014 - "Male rats were subjected to the right nephrectomy and randomized as: sham, no additional intervention; IR, 45 min of left renal pedicle occlusion; rPeC, four cycles of 5-min limb IR administered at the beginning of renal ischemia. "
02/01/2014 - "Groups of male Wistar rats were assigned into sham, ubiquinol, IR (45-min bilateral renal ischemia followed by 24-h reperfusion), and ubiquinol+ IR (ubiquinol 300 mg/kg given orally for 7 consecutive days before IR induction). "
05/01/2014 - "Anesthetized and ventilated rats were randomized into six groups (n = 8/group): sham: after laparotomy, the portal triad was exposed without clamping; IPC was performed with 10 min of partial liver ischemia and 10 min of reperfusion; HePC: three cycles of 5 min with inhalation of helium 70 vol% and intermittent washout; IR: 45 min of ischemia followed by 240 min of reperfusion; IPC-IR: IPC followed by hepatic IR; HePC-IR: pretreatment with helium 70 vol% followed by hepatic IR. "
|3.||Hypertension (High Blood Pressure)
|4.||Herpes Genitalis (Genital Herpes)
|1.||salicylhydroxamic acid (SHAM)